(3-[4-(benzooxazol-2-yloxy)-phenyl]-propyl)-cyclohexyl-ethyl-amine | 841200-86-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (3-[4-(benzooxazol-2-yloxy)-phenyl]-propyl)-cyclohexyl-ethyl-amine
• 英文别名: {3-[4-(benzooxazol-2-yloxy)-phenyl]-propyl}-cyclohexyl-ethyl-amine；N-[3-[4-(1,3-benzoxazol-2-yloxy)phenyl]propyl]-N-ethylcyclohexanamine
• CAS: 841200-86-0
• 化学式: C₂₄H₃₀N₂O₂
• 分子量: 378.514
• InChiKey: ICEHPSYAPXDUNH-UHFFFAOYSA-N

物化性质

• 沸点：
  513.4±60.0 °C(Predicted)
• 密度：
  1.13±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  6.5
• 重原子数：
  28
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  38.5
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2-氯苯并恶唑 、 4-[3-(cyclohexyl-ethyl-amino)-propyl]-phenol 在 caesium carbonate 作用下， 以 丙酮 为溶剂， 以81%的产率得到(3-[4-(benzooxazol-2-yloxy)-phenyl]-propyl)-cyclohexyl-ethyl-amine
  参考文献：
  名称：

  LTA4H modulators and uses thereof

  摘要：

  白三烯A4水解酶（LTA4H）抑制剂，含有它们的组合物，以及用于抑制LTA4H酶活性和治疗、预防或抑制炎症和/或与炎症相关疾病的方法。

  公开号：

  US20080194630A1

文献信息

• [EN] BENZIMIDAZOLE, BENZTHIAZOLE AND BENZOXAZOLE DERIVATIVES AND THEIR USE AS LTA4H MODULATORS<br/>[FR] DERIVES DE BENZIMIDAZOLE, DE BENZTHIAZOLE ET DE BENZOXAZOLE ET UTILISATION DE CEUX-CI COMME MODULATEURS LTA4H
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2005012296A1

  公开（公告）日：2005-02-10

  Leukotriene A4 hydrolase (LTA4H) inhibitors of formula I, compositions containing them, and their use for the inhibition of LTA4H enzyme activity and the treatment, prevention or inhibition of inflammation and/or conditions associated with inflammation, wherein X is selected from the group consisting of NR5, O, and S, with R5 being one of the H and CH3; Y is selected from the group consisting of CH2 and O; R4 is selected from the group consisting of H, OCH3, Cl, F, Br, I, OH, NH2, CN, CF3.

  白三烯A4水解酶（LTA4H）的抑制剂I式，含有它们的组合物，以及它们用于抑制LTA4H酶活性和治疗、预防或抑制炎症和/或与炎症相关疾病的用途，其中X从NR5、O和S组成的组中选择，其中R5是H和CH3中的一个；Y从CH2和O组成的组中选择；R4从H、OCH3、Cl、F、Br、I、OH、NH2、CN、CF3组成的组中选择。
• [EN] BENZIMIDAZOLE, BENZTHIAZOLE AND BENZOXAZOLE DERIVATIVES AND THEIR USE AS LTA4H MODULATORS<br/>[FR] DERIVES DE BENZIMIDAZOLE, BENZTHIAZOLE AND BENZOXAZOLE ET LEUR UTILISATION EN TANT QUE MODULATEURS DE LTA4H
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2005012297A1

  公开（公告）日：2005-02-10

  Leukotriene A4 hydrolase (LTA4H) inhibitors of Formula (I), compositions containing them, and their use for the inhibition of LTA4H enzyme activity and the treatment, prevention or inhibition of inflammation and/or conditions associated with inflammation. Wherein X is selected from the group consisting of NR5, O, and S, with R5 being on of H and CH3; Y is selected from the group consisting; W is selected from the group consisting Of CH2 and CHR1-CH2, with R1 being one H and OH, wherein R1-attached carbon member in said CHR1-CH2 is not directly attached; R4 is selected from the group consisting of H, OCH3, CI, F Br, OH, NH2, CN, CF3 and CH3; R6 is H or F; and R2 and R3 are each independently selected from various groups.

  Leukotriene A4水解酶（LTA4H）的Formula（I）抑制剂，含有它们的组合物以及它们用于抑制LTA4H酶活性和治疗、预防或抑制炎症和/或与炎症相关疾病的用途。其中X选择自NR5，O和S组，其中R5是H和CH3之一; Y选择自组中，W选择自CH2和CHR1-CH2组，其中R1是H和OH之一，其中所述CHR1-CH2中的R1-连接碳成员不直接连接; R4选择自H，OCH3，CI，F Br，OH，NH2，CN，CF3和CH3组; R6是H或F; R2和R3各自独立地选择自各种组。
• LTA4H Modulators
  申请人：Axe U. Frank

  公开号：US20050043379A1

  公开（公告）日：2005-02-24

  Leukotriene A4 hydrolase (LTA4H) inhibitors, compositions containing them, and methods of use for the inhibition of LTA4H enzyme activity and the treatment, prevention or inhibition of inflammation and/or conditions associated with inflammation.

  Leukotriene A4水解酶（LTA4H）抑制剂，含有它们的组合物，以及用于抑制LTA4H酶活性和治疗、预防或抑制炎症和/或与炎症相关的病症的使用方法。
• LTA4H modulators
  申请人：Axe U. Frank

  公开号：US20050043378A1

  公开（公告）日：2005-02-24

  Leukotriene A4 hydrolase (LTA4H) inhibitors, compositions containing them, and methods of use for the inhibition of LTA4H enzyme activity and the treatment, prevention or inhibition of inflammation and/or conditions associated with inflammation.

  Leukotriene A4水解酶（LTA4H）抑制剂，含有它们的组合物，以及用于抑制LTA4H酶活性和治疗、预防或抑制炎症和/或与炎症相关疾病的使用方法。
• BENZIMIDAZOLE, BENZTHIAZOLE AND BENZOXAZOLE DERIVATIVES AND THEIR USE AS LTA4H MODULATORS
  申请人：JANSSEN PHARMACEUTICA N.V.

  公开号：EP1660491A1

  公开（公告）日：2006-05-31